This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 93/4/1224    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hamilton, T. E. Articles by Kopecky, K. J. Search for Related Content PubMed PubMed Citation Articles by Hamilton, T. E. Articles by Kopecky, K. J. Related Collections Thyroid Autoimmunity

Thyrotropin Levels in a Population with No Clinical, Autoantibody, or Ultrasonographic Evidence of Thyroid Disease: Implications for the Diagnosis of Subclinical Hypothyroidism

Programs in Epidemiology (T.E.H., S.D., L.O.) and Cancer Prevention (K.J.K.), Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109; Division of Endocrinology and Metabolism (T.E.H.), University of Washington School of Medicine, Seattle, Washington 98195; and Departments of Epidemiology (S.D.) and Biostatistics (K.J.K.), University of Washington School of Public Health and Community Medicine, Seattle, Washington 98195

Address all correspondence and requests for reprints to: Thomas Hamilton, M.D., Ph.D., Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, M4-A830, P.O. Box 19024, Seattle, Washington 98109-1024. E-mail: tehamilton{at}aol.com.

Context: The current debate regarding whether to decrease the upper limit for the TSH reference range to 2.5 µIU/ml has considerable potential impact on the diagnosis and treatment of subclinical hypothyroidism worldwide.

Objective: We report an analysis of TSH distribution in a population with no evidence of thyroid disease, including a normal thyroid ultrasound.

Design: A subset of the Hanford Thyroid Disease Study cohort was used to examine the TSH distribution in a population having no evidence of thyroid disease, seronegative thyroid autoantibodies, no history of thyroid medications, and a normal thyroid ultrasound. The shape of the TSH distribution was compared with the Gaussian and lognormal distributions.

Setting: This study was performed in the general community.

Participants: Of 1861 Hanford Thyroid Disease Study participants with TSH measured by ELISA who also had thyroid peroxidase antibody measurements, 766 comprised the normal reference group 3 (NRG-3) with no evidence of thyroid disease, including no positive antibodies and normal thyroid ultrasound.

Main Outcome Measure: TSH was measured.

Results: The TSH distribution in the NRG (NRG-3) was right skewed and followed an approximate lognormal distribution. The best estimates of the 97.5th percentile, the percentage above 2.5 µIU/ml, and the percentage above 3.0 µIU/ml for TSH by 3rd generation immunochemiluminometric assay are 4.1 µIU/ml, 20% and 10.2%, respectively.

Conclusion: These results indicate that the TSH reference range should be narrowed and support a value of approximately 4.0 as the upper-reference limit.

This article has been cited by other articles:

				M. Chonchol, G. Lippi, G. Salvagno, G. Zoppini, M. Muggeo, and G. Targher Prevalence of Subclinical Hypothyroidism in Patients with Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1296 - 1300. [Abstract] [Full Text] [PDF]

				What Is the Upper Limit of Normal for TSH? Journal Watch (General), April 10, 2008; 2008(410): 5 - 5. [Full Text]